血管損傷治療市場：傷害別、治療別、エンドユーザー別-2025-2030年の世界予測

血管損傷治療市場は、2023年に215億1,000万米ドルと評価され、2024年には244億5,000万米ドルに達すると予測され、CAGR 13.76％で成長し、2030年には530億4,000万米ドルに達すると予測されています。

血管損傷治療は、外傷、外科的合併症、特定の病状のために起こりうる血管の損傷を管理・修復するためにデザインされた、さまざまな医療介入を包含しています。その必要性は、血管が循環系において重要な役割を果たし、組織の生存性と身体機能全体を支えていることによる。用途としては、緊急外傷治療、血管外科手術、再建術などがあります。最終用途分野は主に病院、外傷センター、専門外科病棟です。

血管損傷治療の市場成長は、外傷の発生率の増加、動脈瘤や血栓症などの血管疾患の有病率の上昇、医療技術の進歩などの要因に影響されます。さらに、高齢者は血管合併症にかかりやすいため、世界人口の高齢化が需要をさらに高めています。血管内手術のような低侵襲手技の急増は、回復時間の短縮と手術リスクの低減をもたらし、大きなビジネスチャンスとなります。企業は最先端機器の開発に投資し、ヘルスケアプロバイダーとのパートナーシップを拡大することで、こうした進歩を活用することができます。

しかし、先進的な血管手術やデバイスの高価格、規制上のハードル、複雑なインターベンションを行うための熟練者の必要性など、市場は限界や課題に直面しています。さらに、地域によるヘルスケアへのアクセス格差が市場成長に影響を及ぼす可能性もあります。

イノベーションの機会は、より良い診断と治療計画の精度を高めるための画像技術の強化、生分解性ステントの開発、血管再生のための幹細胞治療の探求にあります。材料科学の調査も、より耐久性が高く生体適合性の高い人工血管の創出に貢献する可能性があります。市場の競争は激しく、主要企業は差別化を図るために研究開発に多額の投資を行っています。企業は、血管損傷治療を合理化し、幅広い市場への浸透を促進するために、学際的コラボレーションの促進やヘルスケア・インフラの改善に注力すべきです。

市場力学：急速に進化する血管損傷治療市場の主要市場インサイトを公開

血管損傷治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 血管損傷手術の増加
  • 交通事故、切り傷、暴力の増加による外傷発生の増加
  • 心臓関連疾患の治療ソリューションを提供するための病院による共同研究の増加
• 市場抑制要因
  • 血管損傷治療に関連する高コスト
• 市場機会
  • 新興諸国における医療ツーリズムの増加
  • 技術の進歩
• 市場の課題
  • 血管損傷治療に伴う副作用

ポーターの5つの力：血管損傷治療市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、血管損傷治療市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：血管損傷治療市場における外部からの影響の把握

外部マクロ環境要因は、血管損傷治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析血管損傷治療市場における競合情勢の把握

血管損傷治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス血管損傷治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、血管損傷治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨血管損傷治療市場における成功への道筋を描く

血管損傷治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 血管損傷手術の発生率上昇
    • 交通事故、切り傷、暴力の増加による外傷の発生の増加
    • 心臓関連疾患の治療ソリューションを提供するための病院間の連携が増加
  • 抑制要因
    • 血管損傷治療に関連する高コスト
  • 機会
    • 新興諸国における医療ツーリズムの拡大
    • 技術の進歩の加速
  • 課題
    • 血管損傷治療に関連する副作用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 血管損傷治療市場負傷により

• 動脈瘤と仮性動脈瘤
• 動静脈瘻
• 挫傷または内膜フラップ
• 裂傷または切断
• けいれん
• 血栓症

第7章 血管損傷治療市場治療別

• バイパス移植
• 解剖学的バイパス
• 外側動脈縫合術または静脈縫合術
• パッチ血管形成術
• 血栓除去術

第8章 血管損傷治療市場：エンドユーザー別

• 外来手術センター
• 病院

第9章 南北アメリカの血管損傷治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の血管損傷治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの血管損傷治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• Abbott Laboratories
• Aplagon Oy
• Becton, Dickinson, and Company
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cardiva Medical, Inc.
• Cordis Corporation
• Humacyte, Inc.
• Medtronic PLC
• Mentice AB
• Teleflex Incorporated
• Terumo Corporation
• Vasorum Ltd.
• Veryan Medical Ltd
• Vivasure Medical Ltd.

LIST OF FIGURES

• FIGURE 1. VASCULAR INJURY TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. VASCULAR INJURY TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VASCULAR INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VASCULAR INJURY TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ANEURYSM & PSEUDOANEURYSM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY ARTERIOVENOUS FISTULA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY CONTUSION OR INTIMAL FLAP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LACERATION OR TRANSECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY SPASM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY BYPASS GRAFT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY EXTRA ANATOMIC BYPASS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY LATERAL ARTERIORRHAPHY OR VENORRHAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PATCH ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBECTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 34. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 35. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 51. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 52. CHINA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 54. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 55. INDIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 106. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 107. ITALY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 118. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 119. POLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 121. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 122. QATAR VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Vascular Injury Treatment Market was valued at USD 21.51 billion in 2023, expected to reach USD 24.45 billion in 2024, and is projected to grow at a CAGR of 13.76%, to USD 53.04 billion by 2030.

Vascular injury treatment encompasses a range of medical interventions designed to manage and repair damage to blood vessels, which can occur due to trauma, surgical complications, or certain medical conditions. Its necessity is driven by the critical role that blood vessels play in the circulatory system, supporting tissue viability and overall bodily function. Applications include emergency trauma care, vascular surgical procedures, and reconstructive techniques. End-use sectors primarily involve hospitals, trauma centers, and specialized surgical units.

Market growth for vascular injury treatment is influenced by factors such as the increasing incidence of traumatic injuries, rising prevalence of vascular diseases like aneurysms and thrombosis, and advancements in medical technology. Additionally, an aging global population further intensifies demand, as older individuals are more susceptible to vascular complications. The surge in minimally invasive techniques, such as endovascular surgery, represents a significant opportunity, offering faster recovery times and reduced surgical risks. Companies can capitalize on these advancements by investing in developing cutting-edge devices and expanding partnerships with healthcare providers.

However, the market faces limitations and challenges, including the high cost of advanced vascular procedures and devices, regulatory hurdles, and the need for skilled practitioners to perform complex interventions. Furthermore, disparities in healthcare accessibility across different regions can affect market growth.

Innovation opportunities lie in enhancing imaging technologies for better diagnosis and precision in treatment plans, developing biodegradable stents, and exploring stem cell therapy for vascular regeneration. Research into materials science can also contribute to the creation of more durable and biocompatible vascular grafts. The market is characterized by robust competition, with key players investing heavily in research and development to differentiate their offerings. Businesses should focus on fostering interdisciplinary collaboration and improving healthcare infrastructure to streamline vascular injury treatment and facilitate wide-ranging market penetration.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Injury Treatment Market

The Vascular Injury Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of vascular injury surgeries
  • Rise in the occurrence of trauma due to the increase in the road accidents, cuts, violence
  • Increasing number of collaborations by hospital to provide therapeutic solution for heart related diseases
• Market Restraints
  • High cost associated with the vascular injury treatment
• Market Opportunities
  • Growing medical tourism in developing countries
  • Increasing advancement in technologies
• Market Challenges
  • Side effects associated with vascular injury treatment

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Injury Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Injury Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Injury Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Injury Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Injury Treatment Market

A detailed market share analysis in the Vascular Injury Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Injury Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Injury Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Injury Treatment Market

A strategic analysis of the Vascular Injury Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Injury Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Aplagon Oy, Becton, Dickinson, and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cardiva Medical, Inc., Cordis Corporation, Humacyte, Inc., Medtronic PLC, Mentice AB, Teleflex Incorporated, Terumo Corporation, Vasorum Ltd., Veryan Medical Ltd, and Vivasure Medical Ltd..

Market Segmentation & Coverage

This research report categorizes the Vascular Injury Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Injury, market is studied across Aneurysm & Pseudoaneurysm, Arteriovenous Fistula, Contusion or Intimal Flap, Laceration or Transection, Spasm, and Thrombosis.
• Based on Treatment, market is studied across Bypass Graft, Extra Anatomic Bypass, Lateral Arteriorrhaphy or Venorrhaphy, Patch Angioplasty, and Thrombectomy.
• Based on End-User, market is studied across Ambulatory Surgical Center and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of vascular injury surgeries
    • 5.1.1.2. Rise in the occurrence of trauma due to the increase in the road accidents, cuts, violence
    • 5.1.1.3. Increasing number of collaborations by hospital to provide therapeutic solution for heart related diseases
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the vascular injury treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing medical tourism in developing countries
    • 5.1.3.2. Increasing advancement in technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Side effects associated with vascular injury treatment
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vascular Injury Treatment Market, by Injury

• 6.1. Introduction
• 6.2. Aneurysm & Pseudoaneurysm
• 6.3. Arteriovenous Fistula
• 6.4. Contusion or Intimal Flap
• 6.5. Laceration or Transection
• 6.6. Spasm
• 6.7. Thrombosis

7. Vascular Injury Treatment Market, by Treatment

• 7.1. Introduction
• 7.2. Bypass Graft
• 7.3. Extra Anatomic Bypass
• 7.4. Lateral Arteriorrhaphy or Venorrhaphy
• 7.5. Patch Angioplasty
• 7.6. Thrombectomy

8. Vascular Injury Treatment Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Center
• 8.3. Hospital

9. Americas Vascular Injury Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Vascular Injury Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Vascular Injury Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Abbott Laboratories
• 3. Aplagon Oy
• 4. Becton, Dickinson, and Company
• 5. Boston Scientific Corporation
• 6. Cardinal Health, Inc.
• 7. Cardiva Medical, Inc.
• 8. Cordis Corporation
• 9. Humacyte, Inc.
• 10. Medtronic PLC
• 11. Mentice AB
• 12. Teleflex Incorporated
• 13. Terumo Corporation
• 14. Vasorum Ltd.
• 15. Veryan Medical Ltd
• 16. Vivasure Medical Ltd.